Glial cells as a promising therapeutic target of glaucoma: beyond the IOP

Glial cells, a type of non-neuronal cell found in the central nervous system (CNS), play a critical role in maintaining homeostasis and regulating CNS functions. Recent advancements in technology have paved the way for new therapeutic strategies in the fight against glaucoma. While intraocular press...

Full description

Bibliographic Details
Main Authors: Youichi Shinozaki, Kazuhiko Namekata, Xiaoli Guo, Takayuki Harada
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Ophthalmology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fopht.2023.1310226/full
_version_ 1797362413456064512
author Youichi Shinozaki
Kazuhiko Namekata
Xiaoli Guo
Takayuki Harada
author_facet Youichi Shinozaki
Kazuhiko Namekata
Xiaoli Guo
Takayuki Harada
author_sort Youichi Shinozaki
collection DOAJ
description Glial cells, a type of non-neuronal cell found in the central nervous system (CNS), play a critical role in maintaining homeostasis and regulating CNS functions. Recent advancements in technology have paved the way for new therapeutic strategies in the fight against glaucoma. While intraocular pressure (IOP) is the most well-known modifiable risk factor, a significant number of glaucoma patients have normal IOP levels. Because glaucoma is a complex, multifactorial disease influenced by various factors that contribute to its onset and progression, it is imperative that we consider factors beyond IOP to effectively prevent or slow down the disease’s advancement. In the realm of CNS neurodegenerative diseases, glial cells have emerged as key players due to their pivotal roles in initiating and hastening disease progression. The inhibition of dysregulated glial function holds the potential to protect neurons and restore brain function. Consequently, glial cells represent an enticing therapeutic candidate for glaucoma, even though the majority of glaucoma research has historically concentrated solely on retinal ganglion cells (RGCs). In addition to the neuroprotection of RGCs, the proper regulation of glial cell function can also facilitate structural and functional recovery in the retina. In this review, we offer an overview of recent advancements in understanding the non-cell-autonomous mechanisms underlying the pathogenesis of glaucoma. Furthermore, state-of-the-art technologies have opened up possibilities for regenerating the optic nerve, which was previously believed to be incapable of regeneration. We will also delve into the potential roles of glial cells in the regeneration of the optic nerve and the restoration of visual function.
first_indexed 2024-03-08T16:06:40Z
format Article
id doaj.art-af970234dfef4ba4a119338b939a20dc
institution Directory Open Access Journal
issn 2674-0826
language English
last_indexed 2024-03-08T16:06:40Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Ophthalmology
spelling doaj.art-af970234dfef4ba4a119338b939a20dc2024-01-08T05:13:16ZengFrontiers Media S.A.Frontiers in Ophthalmology2674-08262024-01-01310.3389/fopht.2023.13102261310226Glial cells as a promising therapeutic target of glaucoma: beyond the IOPYouichi ShinozakiKazuhiko NamekataXiaoli GuoTakayuki HaradaGlial cells, a type of non-neuronal cell found in the central nervous system (CNS), play a critical role in maintaining homeostasis and regulating CNS functions. Recent advancements in technology have paved the way for new therapeutic strategies in the fight against glaucoma. While intraocular pressure (IOP) is the most well-known modifiable risk factor, a significant number of glaucoma patients have normal IOP levels. Because glaucoma is a complex, multifactorial disease influenced by various factors that contribute to its onset and progression, it is imperative that we consider factors beyond IOP to effectively prevent or slow down the disease’s advancement. In the realm of CNS neurodegenerative diseases, glial cells have emerged as key players due to their pivotal roles in initiating and hastening disease progression. The inhibition of dysregulated glial function holds the potential to protect neurons and restore brain function. Consequently, glial cells represent an enticing therapeutic candidate for glaucoma, even though the majority of glaucoma research has historically concentrated solely on retinal ganglion cells (RGCs). In addition to the neuroprotection of RGCs, the proper regulation of glial cell function can also facilitate structural and functional recovery in the retina. In this review, we offer an overview of recent advancements in understanding the non-cell-autonomous mechanisms underlying the pathogenesis of glaucoma. Furthermore, state-of-the-art technologies have opened up possibilities for regenerating the optic nerve, which was previously believed to be incapable of regeneration. We will also delve into the potential roles of glial cells in the regeneration of the optic nerve and the restoration of visual function.https://www.frontiersin.org/articles/10.3389/fopht.2023.1310226/fulladeno-associated virusastrocytescell transplantationglaucomaintraocular pressuremicroglia
spellingShingle Youichi Shinozaki
Kazuhiko Namekata
Xiaoli Guo
Takayuki Harada
Glial cells as a promising therapeutic target of glaucoma: beyond the IOP
Frontiers in Ophthalmology
adeno-associated virus
astrocytes
cell transplantation
glaucoma
intraocular pressure
microglia
title Glial cells as a promising therapeutic target of glaucoma: beyond the IOP
title_full Glial cells as a promising therapeutic target of glaucoma: beyond the IOP
title_fullStr Glial cells as a promising therapeutic target of glaucoma: beyond the IOP
title_full_unstemmed Glial cells as a promising therapeutic target of glaucoma: beyond the IOP
title_short Glial cells as a promising therapeutic target of glaucoma: beyond the IOP
title_sort glial cells as a promising therapeutic target of glaucoma beyond the iop
topic adeno-associated virus
astrocytes
cell transplantation
glaucoma
intraocular pressure
microglia
url https://www.frontiersin.org/articles/10.3389/fopht.2023.1310226/full
work_keys_str_mv AT youichishinozaki glialcellsasapromisingtherapeutictargetofglaucomabeyondtheiop
AT kazuhikonamekata glialcellsasapromisingtherapeutictargetofglaucomabeyondtheiop
AT xiaoliguo glialcellsasapromisingtherapeutictargetofglaucomabeyondtheiop
AT takayukiharada glialcellsasapromisingtherapeutictargetofglaucomabeyondtheiop